Hospital Cost Benefit

Collatamp G has demonstrated a 50-85% reduction in surgical site infections across 42 clinical studies involving more than 4700 patients.

In addition to improved patient outcomes, Collatamp G demonstrates hospital cost savings from reduced length of stay as well as from reduced surgical revisions and repeat surgeries.

Used for 20 years in two million patients worldwide, Collatamp G has no reported adverse events.

Now available in Canada, Collatamp G can be used as a local adjunct to systemic antibiotic prophylaxis and the Safer Healthcare Now surgical site infection bundle in high-risk surgical patients.

Even at low surgical site infection rates, Collatamp G offers hospitals a cost benefit.

For example, prophylactic use of Collatamp G in high-risk surgical patients results in break-even costs at the following procedural infection rates:

Cardiac surgery: 1.7%
Hip replacement surgery: 2.1%
Colorectal surgery: 5.6%

These rates of infection are far below Canadian benchmark data.

About Surgical Site Infections

Improve Patient Safety, Reduce Costs and Increase Patient Throughput By Preventing Surgical Site Infections

Preventing and Treating Surgical Site Infections with Collatamp G

Patient Criteria

Hospital Cost Benefit

Request a Cost-Benefit Analysis or Sample for Product Evaluation

Download Ordering Information Form

Hospital Cost Benefit